• Latest Posts

Merck puts up to $37B into Orna Therapeutics circular RNA collaboration

Immutep reports positive data from cancer study

BioMed X Institute and Merck start new oncology research project

Kelun-Biotech announces joint license agreement with MSD for drug targeting solid tumors

Five companies personalizing treatments with 3D printed drugs

Global call for scientists and inventors to form new startup


Amphista Lands Megadeals to Smash Cancer using Protein Degradation

Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis

International Collaboration on Brink of Resurrecting Northern White Rhinos

Update: First Ever Ebola Vaccine Gets US and EU Approval

UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome